KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$4.0 million.

  • Bristol Myers Squibb's Exchange Rate Effect fell 10519.48% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year decrease of 5113.64%. This contributed to the annual value of -$137.0 million for FY2024, which is 40444.44% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Exchange Rate Effect stood at -$4.0 million for Q3 2025, which was down 10519.48% from $128.0 million recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Exchange Rate Effect peaked at $128.0 million during Q2 2025, and registered a low of -$147.0 million during Q4 2024.
  • Its 5-year average for Exchange Rate Effect is -$1.9 million, with a median of -$8.0 million in 2023.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 49444.44% in 2022, then skyrocketed by 68181.82% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Exchange Rate Effect (Quarter) stood at -$54.0 million in 2021, then surged by 275.93% to $95.0 million in 2022, then fell by 17.89% to $78.0 million in 2023, then crashed by 288.46% to -$147.0 million in 2024, then skyrocketed by 97.28% to -$4.0 million in 2025.
  • Its Exchange Rate Effect was -$4.0 million in Q3 2025, compared to $128.0 million in Q2 2025 and $66.0 million in Q1 2025.